Search

Search Constraints

You searched for: Author/Creator Ruff, Christian T

Search Results

1. A polygenic risk score predicts atrial fibrillation in cardiovascular disease. (18th August 2022)

2. Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Issue 9984 (6th June 2015)

4. Edoxaban and implantable cardiac device interventions: insights from the ENGAGE AF-TIMI 48 trial. Issue 2 (19th November 2018)

5. Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF–TIMI 48. Issue 2 (1st March 2019)

6. Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF–TIMI 48. Issue 2 (March 2019)

7. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial. Issue 10161 (24th November 2018)

8. Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial. Issue 3 (5th November 2019)

10. Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Issue 9984 (6th June 2015)